BioCorRx (BICX) Share-based Compensation (2012 - 2026)
BioCorRx (BICX) posted Share-based Compensation of $351258.0 for Q4 2025, up 2087.16% sequentially from $16060.0 in Q3 2025, and up 189.32% YoY from $121408.0 in Q4 2024.
BioCorRx (BICX) Share-based Compensation (2012 - 2026) Analysis & Trends
BioCorRx has reported Share-based Compensation for 14 years, with the latest figure at $351258.0 in Q4 2025.
- Quarterly Share-based Compensation rose 189.32% year-over-year to $351258.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $398033.0 (up 84.06% YoY) and the FY2025 annual result came in at $592604.0, up 158.1% from the prior year.
- Share-based Compensation improved to $351258.0 in Q4 2025 per BICX's latest filing, from $16060.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $351258.0 in Q4 2025 and troughed at -$172429.0 in Q4 2022.
- A 5-year average of $30148.2 and a median of $29261.0 in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2021 and 2022: Share-based Compensation tumbled 154.5% in 2021, then soared 320.37% in 2022.
- Over 5 years, Share-based Compensation stood at -$157625.0 in 2021, then declined by 9.39% to -$172429.0 in 2022, then soared by 122.19% to $38263.0 in 2023, then jumped by 217.3% to $121408.0 in 2024, then jumped by 189.32% to $351258.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $351258.0, $16060.0, and $30715.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 85.00 Mn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | -3.00 Mn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 659,000.00 |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 38.43 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 199.20 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 25.83 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 9.05 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 4.13 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,375.00 |
| Mar 31, 2026 | 108,375.00 |
| Dec 31, 2025 | 351,258.00 |
| Dec 31, 2025 | 351,258.00 |
| Sep 30, 2025 | 16,060.00 |
| Sep 30, 2025 | 16,060.00 |
| Jun 30, 2025 | 30,715.00 |
| Jun 30, 2025 | 30,715.00 |
| Mar 31, 2025 | 35,099.00 |
| Mar 31, 2025 | 35,099.00 |
| Dec 31, 2024 | 121,408.00 |
| Dec 31, 2024 | 121,408.00 |
| Sep 30, 2024 | 29,261.00 |
| Sep 30, 2024 | 29,261.00 |
| Jun 30, 2024 | 30,480.00 |
| Jun 30, 2024 | 30,480.00 |
| Mar 31, 2024 | 48,450.00 |
| Mar 31, 2024 | 48,450.00 |
| Dec 31, 2023 | 38,263.00 |
| Dec 31, 2023 | 38,263.00 |